Will Gilead Price its Coronavirus Drug for Public Good or Company Profit?

Gilead also aims to increase worldwide manufacturing to supply over a million coronavirus patients by year-end, rising to several million in 2021, if required. The company has not disclosed its pricing plans.

from Top World News- News18.com https://ift.tt/2SYF7Yz